Sou Hu Cai Jing·2025-12-04 11:56Core Insights - The stock of Chunli Medical (688236) closed at 24.21 yuan on December 4, 2025, with a decrease of 0.49% and a trading volume of 8,865 hands, amounting to 21.43 million yuan in total transaction value [1][2]. Fund Flow Analysis - On December 4, 2025, the net outflow of main funds was 233.45 thousand yuan, accounting for 10.89% of the total transaction value, while retail investors saw a net inflow of 71.26 thousand yuan, representing 3.32% of the total transaction value [1][2]. - Over the past five days, the stock experienced fluctuating fund flows, with notable net inflows and outflows from different investor categories [2]. Company Performance Metrics - Chunli Medical's total market capitalization is 9.286 billion yuan, with a net asset value of 2.986 billion yuan and a net profit of 192 million yuan [3]. - The company reported a significant increase in revenue and profit for the first three quarters of 2025, with a year-on-year revenue growth of 48.75% and a net profit increase of 213.21% [3]. - The gross profit margin stands at 67.27%, significantly higher than the industry average of 51.22% [3]. Industry Ranking - In comparison to the medical device industry averages, Chunli Medical ranks 38th in total market capitalization and 51st in net assets among 124 companies [3]. - The company's price-to-earnings ratio (36.36) is lower than the industry average (60.57), indicating a potentially favorable valuation [3]. Analyst Ratings - In the last 90 days, 8 institutions have rated the stock, with 7 buy ratings and 1 hold rating, and the average target price set at 31.8 yuan [4].